Company / R&D per Share
Perrigo R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.70
FY2025
5-year range
$0.70 / $0.91
FY2021-FY2025
Trend
-15.6%
vs FY2024
Sector context
#163 of 208
Health Care
What the data says
Perrigo's r&d per share of $0.70 is lower than 78% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 10 years, ranging from $0.70 in FY2025 to $1.59 in FY2016.
Based on SEC 10-K filings.
0.70 in FY2025 with a 5-year CAGR of -4.5%.
Declined from $0.91 to $0.70 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -7.6%
- 5-Year CAGR
- -4.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 208This company $0.70 Sector average $12.19
▼
-94.3% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 15.6% year-over-year.
- Ranks #163 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.70 | -15.6% |
| FY2024 | $0.83 | -8.9% |
| FY2023 | $0.91 | +2.5% |
| FY2022 | $0.89 | +1.6% |
| FY2021 | $0.87 | -0.8% |
| FY2020 | $0.88 | -25.2% |
| FY2019 | $1.18 | -8.4% |
| FY2018 | $1.28 | +9.2% |
| FY2017 | $1.18 | -26.1% |
| FY2016 | $1.59 | -19.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026